Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | NAVARRETE-MONTALVO, DANIELA PAZ |
| Género | Mujer |
| Área Principal WOS | Oncology; |
| Afiliación Principal | Universidad De Valparaíso |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Oncology | 2 |
| Scopus | #Pub |
|---|---|
| Oncology | 1 |
| Cancer Research | 1 |
| SciELO | #Pub |
|---|
| Autor | Género | # Pub |
|---|---|---|
| CALAF-SARRAT, GLORIA MONSERRAT | Mujer | 2 |
| LEON-GONZALEZ, MARIANA | Mujer | 1 |
| GONZALEZ ALVAREZ, RAUL | Hombre | 1 |
| MONTALVO-VILLALBA, MARIA TERESA | Mujer | 2 |
| GONZALEZ M, NICOLAS | Hombre | 1 |
| JIMENEZ A, ANDREA | Mujer | 1 |
| ECHIBURU-CHAU, CARLOS | Hombre | 1 |
| DANIELA NAVARRETE, M. | - | 1 |
| ALVAREZ, RAÚL GONZÁLEZ | Hombre | 1 |
| GONZÁLEZ, NICOLÁS M. | Hombre | 1 |
| JIMÉNEZ, ANDREA A. | Mujer | 1 |
| Año | Firma | Institución (Incites asoc.) | H Index | Average Percentile | Impact Citation | Impact Relative World | Impact Journal Normalized Citation | Impact Category Normalized Citation | Percentage Cited | Percentage Top 1 | Percentage Top 10 | Percentage Journal Q1 | Percentage Journal Q2 | Percentage Journal Q3 | Percentage Journal Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | Montalvo, Daniela Navarrete | Universidad de Valparaiso | 1.0 | 95.4 | 1.0 | 0.1 | 0.1 | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 |
| Título | Año | Citas | Tipo | Revista | Indexada |
|---|---|---|---|---|---|
| Vimentin And Notch As Biomarkers For Breast Cancer Progression | 2014 | 17 | artículo de investigación | Oncology Letters | WoS Scopus |
| Patterns Of Recurrence And Survival In Breast Cancer | 2008 | 1 | artículo de investigación | Oncology Reports | WoS Scopus |
| Palabra Clave | #Pub |
|---|---|
| local recurrence | 1 |
| vimentin | 1 |
| transformation | 1 |
| tamoxifen | 1 |
| survival | 1 |
| surveillance | 1 |
| stem-cells | 1 |
| recurrence | 1 |
| receptor status | 1 |
| radiation | 1 |
| proliferation | 1 |
| prognostic-factors | 1 |
| primary melanoma progression | 1 |
| pathways | 1 |
| notch | 1 |
| activation | 1 |
| growth | 1 |
| gene-expression | 1 |
| follow-up | 1 |
| expression | 1 |
| estrogen | 1 |
| epithelial-cells | 1 |
| conservative surgery | 1 |
| carcinomas | 1 |
| carcinoma in-situ | 1 |
| breast cells | 1 |
| breast cancer | 1 |
| biomarkers | 1 |
| beta-catenin | 1 |